Recurrent Clostridium difficile infection in a patient with selective IgG1 deficiency treated with intravenous immune globulin and Saccharomyces boulardii.
Hassett
J
J
Department of Medicine, Mount Sinai Medical Center, New York, New York, USA.
Meyers
S
S
McFarland
L
L
Mulligan
M E
ME
D000907:Antibodies, Bacterial / Q000097:blood; D001427:Bacterial Toxins / Q000032:analysis; D016360:Clostridioides difficile / Q000276:immunology / Q000302:isolation & purification / Q000378:metabolism; D003967:Diarrhea / Q000150:complications / Q000276:immunology / Q000382:microbiology / Q000628:therapy*; D004761:Enterocolitis, Pseudomembranous / Q000150:complications / Q000276:immunology / Q000382:microbiology / Q000628:therapy*; D005260:Female; D006801:Humans; D017099:IgG Deficiency / Q000150:complications*; D007074:Immunoglobulin G / Q000627:therapeutic use; D016756:Immunoglobulins, Intravenous / Q000627:therapeutic use*; D008875:Middle Aged; D012008:Recurrence; D012440:Saccharomyces / Q000502:physiology*
D000907:Antibodies, Bacterial; D001427:Bacterial Toxins; D007074:Immunoglobulin G; D016756:Immunoglobulins, Intravenous